Global Endocrine Peptides Test Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 149103
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 105
  • list Medical Devices

Endocrine peptide test is used for the measurement of the level of c-peptide present in the blood. C-peptide and insulin are usually found in equivalent amounts. 

Scope of the Report:

The worldwide market for Endocrine Peptides Test is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Endocrine Peptides Test in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Quest Diagnostics

Siemens Healthcare

Abbott Laboratories

bioMerieux

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Estradiol (E2)

Dehydroepiandrosterone Sulfate (DHEAS)

Human Chorionic Gonadotropin (hCG)

Progesterone, Luteinizing Hormone (LH)

Thyroid Stimulating Hormone (TSH)

Thyroid Prolactin

Others

Market Segment by Applications, can be divided into

Hospitals

Physicians’ offices

Commercial Laboratories

Health Care Centers

There are 15 Chapters to deeply display the global Endocrine Peptides Test market.

Chapter 1, to describe Endocrine Peptides Test Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Endocrine Peptides Test, with sales, revenue, and price of Endocrine Peptides Test, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Endocrine Peptides Test, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Endocrine Peptides Test market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Endocrine Peptides Test sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Endocrine Peptides Test Introduction

1.2 Market Analysis by Type

1.2.1 Estradiol (E2)

1.2.2 Dehydroepiandrosterone Sulfate (DHEAS)

1.2.3 Human Chorionic Gonadotropin (hCG)

1.2.4 Progesterone, Luteinizing Hormone (LH)

1.2.5 Thyroid Stimulating Hormone (TSH)

1.2.6 Thyroid Prolactin

1.2.7 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Physicians’ offices

1.3.3 Commercial Laboratories

1.3.4 Health Care Centers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Quest Diagnostics

2.1.1 Business Overview

2.1.2 Endocrine Peptides Test Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Quest Diagnostics Endocrine Peptides Test Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Siemens Healthcare

2.2.1 Business Overview

2.2.2 Endocrine Peptides Test Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Siemens Healthcare Endocrine Peptides Test Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Abbott Laboratories

2.3.1 Business Overview

2.3.2 Endocrine Peptides Test Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Abbott Laboratories Endocrine Peptides Test Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 bioMerieux

2.4.1 Business Overview

2.4.2 Endocrine Peptides Test Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 bioMerieux Endocrine Peptides Test Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Endocrine Peptides Test Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Endocrine Peptides Test Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Endocrine Peptides Test Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Endocrine Peptides Test Manufacturer Market Share in 2017

3.3.2 Top 6 Endocrine Peptides Test Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Endocrine Peptides Test Market Analysis by Regions

4.1 Global Endocrine Peptides Test Sales, Revenue and Market Share by Regions

4.1.1 Global Endocrine Peptides Test Sales and Market Share by Regions (2013-2018)

4.1.2 Global Endocrine Peptides Test Revenue and Market Share by Regions (2013-2018)

4.2 North America Endocrine Peptides Test Sales and Growth Rate (2013-2018)

4.3 Europe Endocrine Peptides Test Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Endocrine Peptides Test Sales and Growth Rate (2013-2018)

4.5 South America Endocrine Peptides Test Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Endocrine Peptides Test Sales and Growth Rate (2013-2018)

5 North America Endocrine Peptides Test by Countries

5.1 North America Endocrine Peptides Test Sales, Revenue and Market Share by Countries

5.1.1 North America Endocrine Peptides Test Sales and Market Share by Countries (2013-2018)

5.1.2 North America Endocrine Peptides Test Revenue and Market Share by Countries (2013-2018)

5.2 United States Endocrine Peptides Test Sales and Growth Rate (2013-2018)

5.3 Canada Endocrine Peptides Test Sales and Growth Rate (2013-2018)

5.4 Mexico Endocrine Peptides Test Sales and Growth Rate (2013-2018)

6 Europe Endocrine Peptides Test by Countries

6.1 Europe Endocrine Peptides Test Sales, Revenue and Market Share by Countries

6.1.1 Europe Endocrine Peptides Test Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Endocrine Peptides Test Revenue and Market Share by Countries (2013-2018)

6.2 Germany Endocrine Peptides Test Sales and Growth Rate (2013-2018)

6.3 UK Endocrine Peptides Test Sales and Growth Rate (2013-2018)

6.4 France Endocrine Peptides Test Sales and Growth Rate (2013-2018)

6.5 Russia Endocrine Peptides Test Sales and Growth Rate (2013-2018)

6.6 Italy Endocrine Peptides Test Sales and Growth Rate (2013-2018)

7 Asia-Pacific Endocrine Peptides Test by Countries

7.1 Asia-Pacific Endocrine Peptides Test Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Endocrine Peptides Test Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Endocrine Peptides Test Revenue and Market Share by Countries (2013-2018)

7.2 China Endocrine Peptides Test Sales and Growth Rate (2013-2018)

7.3 Japan Endocrine Peptides Test Sales and Growth Rate (2013-2018)

7.4 Korea Endocrine Peptides Test Sales and Growth Rate (2013-2018)

7.5 India Endocrine Peptides Test Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Endocrine Peptides Test Sales and Growth Rate (2013-2018)

8 South America Endocrine Peptides Test by Countries

8.1 South America Endocrine Peptides Test Sales, Revenue and Market Share by Countries

8.1.1 South America Endocrine Peptides Test Sales and Market Share by Countries (2013-2018)

8.1.2 South America Endocrine Peptides Test Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Endocrine Peptides Test Sales and Growth Rate (2013-2018)

8.3 Argentina Endocrine Peptides Test Sales and Growth Rate (2013-2018)

8.4 Colombia Endocrine Peptides Test Sales and Growth Rate (2013-2018)

9 Middle East and Africa Endocrine Peptides Test by Countries

9.1 Middle East and Africa Endocrine Peptides Test Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Endocrine Peptides Test Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Endocrine Peptides Test Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Endocrine Peptides Test Sales and Growth Rate (2013-2018)

9.3 UAE Endocrine Peptides Test Sales and Growth Rate (2013-2018)

9.4 Egypt Endocrine Peptides Test Sales and Growth Rate (2013-2018)

9.5 Nigeria Endocrine Peptides Test Sales and Growth Rate (2013-2018)

9.6 South Africa Endocrine Peptides Test Sales and Growth Rate (2013-2018)

10 Global Endocrine Peptides Test Market Segment by Type

10.1 Global Endocrine Peptides Test Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Endocrine Peptides Test Sales and Market Share by Type (2013-2018)

10.1.2 Global Endocrine Peptides Test Revenue and Market Share by Type (2013-2018)

10.2 Estradiol (E2) Sales Growth and Price

10.2.1 Global Estradiol (E2) Sales Growth (2013-2018)

10.2.2 Global Estradiol (E2) Price (2013-2018)

10.3 Dehydroepiandrosterone Sulfate (DHEAS) Sales Growth and Price

10.3.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Sales Growth (2013-2018)

10.3.2 Global Dehydroepiandrosterone Sulfate (DHEAS) Price (2013-2018)

10.4 Human Chorionic Gonadotropin (hCG) Sales Growth and Price

10.4.1 Global Human Chorionic Gonadotropin (hCG) Sales Growth (2013-2018)

10.4.2 Global Human Chorionic Gonadotropin (hCG) Price (2013-2018)

10.5 Progesterone, Luteinizing Hormone (LH) Sales Growth and Price

10.5.1 Global Progesterone, Luteinizing Hormone (LH) Sales Growth (2013-2018)

10.5.2 Global Progesterone, Luteinizing Hormone (LH) Price (2013-2018)

10.6 Thyroid Stimulating Hormone (TSH) Sales Growth and Price

10.6.1 Global Thyroid Stimulating Hormone (TSH) Sales Growth (2013-2018)

10.6.2 Global Thyroid Stimulating Hormone (TSH) Price (2013-2018)

10.7 Thyroid Prolactin Sales Growth and Price

10.7.1 Global Thyroid Prolactin Sales Growth (2013-2018)

10.7.2 Global Thyroid Prolactin Price (2013-2018)

10.8 Others Sales Growth and Price

10.8.1 Global Others Sales Growth (2013-2018)

10.8.2 Global Others Price (2013-2018)

11 Global Endocrine Peptides Test Market Segment by Application

11.1 Global Endocrine Peptides Test Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Physicians’ offices Sales Growth (2013-2018)

11.4 Commercial Laboratories Sales Growth (2013-2018)

11.5 Health Care Centers Sales Growth (2013-2018)

12 Endocrine Peptides Test Market Forecast (2018-2023)

12.1 Global Endocrine Peptides Test Sales, Revenue and Growth Rate (2018-2023)

12.2 Endocrine Peptides Test Market Forecast by Regions (2018-2023)

12.2.1 North America Endocrine Peptides Test Market Forecast (2018-2023)

12.2.2 Europe Endocrine Peptides Test Market Forecast (2018-2023)

12.2.3 Asia-Pacific Endocrine Peptides Test Market Forecast (2018-2023)

12.2.4 South America Endocrine Peptides Test Market Forecast (2018-2023)

12.2.5 Middle East and Africa Endocrine Peptides Test Market Forecast (2018-2023)

12.3 Endocrine Peptides Test Market Forecast by Type (2018-2023)

12.3.1 Global Endocrine Peptides Test Sales Forecast by Type (2018-2023)

12.3.2 Global Endocrine Peptides Test Market Share Forecast by Type (2018-2023)

12.4 Endocrine Peptides Test Market Forecast by Application (2018-2023)

12.4.1 Global Endocrine Peptides Test Sales Forecast by Application (2018-2023)

12.4.2 Global Endocrine Peptides Test Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Endocrine Peptides Test Picture

Table Product Specifications of Endocrine Peptides Test

Figure Global Sales Market Share of Endocrine Peptides Test by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery